BP003794: Biotinylated Human HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) Monomer Protein with the C-His-Avi Tag
Source: The recombinant Biotinylated Human HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) Monomer Protein, (amino acids Gly25-Thr305(HLA-A*24:02), Ile21-Met119(B2M)and IMPKAGLLI peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP003793: Human HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) Tetramer Protein with the C-His-Avi Tag
Source: The recombinant Human HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) Tetramer Protein, (amino acids Gly25-Thr305(HLA-A*24:02), Ile21-Met119(B2M)and IMPKAGLLI peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP003643: Human HLA-A*02:01&B2M&MART-1 (ELAGIGILTV) Tetramer Protein with the C-His-Avi Tag
Source: The recombinant Human HLA-A*02:01&B2M&MART-1 (ELAGIGILTV) Tetramer Protein, (amino acids Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M)and ELAGIGILTV peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP003631: HLA-A*02:01&B2M&HPV 16 E6 (KLPQLCTEL) Monomer Protein with the C-His-Avi Tag
Source: The recombinant HLA-A*02:01&B2M&HPV 16 E6 (KLPQLCTEL) Monomer Protein, (amino acids Gly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M)and KLPQLCTEL peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.- nucleophosmin
- 10
- C. et al. “Abstract P5-04-07: GDC-9545: A novel ER antagonist and clinical candidate that combines desirable mechanistic and pre-clinical DMPK attributes”
- and inhibits MAPK pathway signaling. BI-3406 (BI3406) binds to the catalytic domain of SOS1
- 98 nM (BRD3 BD2)
- highly selective against other CDKs (>60 fold).
CAS No.: 2416874-75-2
IUPAC/Chemical Name: (R)-1-cyanobutan-2-yl ((S)-1-(3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)phenyl)ethyl)carbamate
Molecular Formula: C16H25N5•2HCl
Molecular Weight: 360.3
Purity: >99% pure by Achiral and Chiral HPLCs
QC: Achiral and Chiral HPLCs"""""""